Scout | Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)

Opportunity: NICHD (NIH) funding to develop or improve technologies that boost fertility outcomes, especially in assisted reproductive technologies (ART). Aimed at moving validated, innovative ideas toward future clinical development.
Why it matters: Infertility affects about 15% of couples, with male and female factors contributing equally. ART use has doubled in the …

Agency: Department of Health and Human Services

infertility technologies

assisted reproductive technologies (ART)

in vitro fertilization (IVF)

fertility therapeutics (drugs/gene therapy)

reproductive health devices

fertility diagnostics and screening

fertility preservation

AI/ML in reproductive medicine

preclinical IND/IDE-enabling studies

NICHD R61/R33 phased award

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Already have an account? Sign In

Trusted by 500+ Happy Customers